Collaboration and coordination with local government TB program officials are critical for ensuring transparency and a shared understanding of the study’s purpose, methods, consent process, logistics, and potential implications for India’s national TB control efforts.

PLOS Medicine:  Dr. Amita Gupta and colleagues discuss the scientific and ethical basis for including pregnant and lactation women, children, and HIV+ patients in tuberculosis therapeutic clinical trials.

Maunank Shah and colleagues invented HIV-ASSIST, an online decision-making tool that helps clinicians determine what antiretroviral therapies will best meet the needs of individual HIV patients. This paper in JAIDS discusses what they found in testing the tool's validity.

NEJM: Dr. Kathleen Page and colleagues offer guidance for clinicians on meeting the needs of patients in an era of punitive immigration policy

Lancet HIV: This paper summarizes findings of the Long acting/Extended Release Antiretroviral Resource Program workshop, and offers  recommendations for developing ARV products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women

In 2016, the US Preventative Task Force issued guidance to recommend screening for LTBI in high risk populations, based on the evidence that treatment can prevent progression to active TB. Dr. Maunank Shah breaks down what clinicians should know about LTBI screening and treatment.